1.The characteristic analysis on intestinal metabolism of Pueraria lobata (Willd.)Ohwi
Hewei LI ; Tong ZHAO ; Ling DONG ; Gang WANG ; Honghuan DONG ; Yanjiang QIAO
International Journal of Traditional Chinese Medicine 2014;36(2):131-134
Objective To establish a method to compare the difference of exposure component of oral taking different part ofPueraria Lobata (Willd.) Ohwi in intestine.Methods After the incubation of puerarin,extraction Radix Puerariae and Flos Puerariae with S9,the mixtures were centrifuged to get the supernatant for analysis with HPLC.Results The research showed that the metabolic rate of puerarin was higher than that of extractions because of the concentration of enzyme.The difference between the fingerprints of Radix Puerariae and Flos Puerariae Lobata indicated that there was a difference of chemical components in such two parts of Kudzuvine Root.Conclusion The profile of intestinal metabolism can be revealed in the research of gut wall metabolism in the course of intestinal absorption by S9 incubation.
2.Comparing studies of silybin metabolism in normal rats and liver injury model rats
Yang LIU ; Shuofeng ZHANG ; Wenning YANG ; Guoqing OUYANG ; Xiaoyan GAO ; Baosheng ZHAO ; Honghuan DONG ; Lei ZHANG ; Liying LIU
International Journal of Traditional Chinese Medicine 2012;34(8):700-702
Objective To research the metabolism and distribution ofsilybin in normal rats and liver injury model rats.Methods The normal rats group and immunity liver injury rat models were fed with the same dose ofsilybin capsule,and HPLC was used to determine the silybin concentration in biological samples in different time.Results The silybin concentration in the normal group in biological samples was higher than the model group at different time.In the normal group,the consequence of silybin concentration in each viscera distribution from top to bottom was liver>kidneys>plasma>heart,while in the model group the fact was kidneys>heart>liver>plasma.Conclusion The difference of metabolism and distribution of silybin in normal rats and liver damage model rats was obvious.
3.In Vitro Dissolution Feature of Chuangxiong Powder
Yang LIU ; Beiran LV ; Baosheng ZHAO ; Guopeng WANG ; Xiaoyan HAN ; Lei ZHANG ; Honghuan DONG ; Meiling ZHU ; Li WEI ; Mingmin TANG
Chinese Journal of Information on Traditional Chinese Medicine 2014;(2):88-91
Objective To compare the dissolution of Chuangxiong powder in different medium and discuss the dissolution characteristics in vitro of Changxiong powder. Methods The paddle method was adopted, the UV spectrophotometric method was developed to determine the in vitro dissolution quantity of Changxiong powder in five medium (water, 0.1 mol/L hydrochloric acid, acetate buffer of pH 4.5, phosphate buffer of pH 6.8, phosphate buffer of pH 7.4) with ferulic acid as index, and evaluated by drawing the dissolution curve and using the similar factor method and Weibull model. Results The dissolution quantity of Changxiong oral powder in five medium was different. The dissolution quantity in water, 0.1 mol/L hydrochloric acid, acetate buffer of pH 4.5 and phosphate buffer of pH 6.8 was similar and fit Weibull model, but it mutated in phosphate buffer of pH 7.4 and reached the maximum amount at 30 min. Conclusion The dissolution quantity of Changxiong powder is gradually increasing and the time is shorted in the medium from acidic to neutral then to alkaline. Dissolution curve is similar in the acidic and neutral medium. Changxiong powder dissolves out fast and completely in the alkaline medium.
4.Effects of Berberine Hydrochloride on the Pharmacokinetics of Tacrolimus in Rats
Yuanxia YANG ; Kebo ZHONG ; Xing PAN ; Honghuan ZHAO ; Liqing WANG
China Pharmacy 2019;30(5):596-601
OBJECTIVE: To study the effects of berberine hydrochloride on the pharmacokinetics of tacrolimus in rats after single or multiple administration, and to provide reference for clinical combination therapy. METHODS: 30 rats were randomly divided into 5 groups, with 6 rats in each group: group one was treated with single administration of tacrolimus; group two was treated with tacrolimus intragastrically, twice a day, for consecutive 1 week; group three was treated with single administration of berberine hydrochloride, 5 min later given single administration of tacrolimus; group four was treated with tacrolimus intragastrically, twice a day, for consecutive 1 week, and then given tacrolimus intragastrically once 5 min after intragastric administration of berberine hydrochloride on the 8th day; group five was treated with berberine hydrochloride intragastrically, twice a day, and given tacrolimus intragastrically every 5 min, for consecutive 8 d. The doses of berberine hydrochloride and tacrolimus were 200 mg/kg and 0.945 mg/kg. The blood samples 0.3 mL were collected from posterior orbital venous plexus of rats 0, 5, 15, 30 min and 1, 2, 3, 4, 6, 8, 12 h after last intragastric administration of tacrolimus. The concentration of tacrolimus in rat whole blood was determined by LC-MS/MS. DAS 2.0 software was used for pharmacokinetic study. RESULTS: Compared with group one, the pharmacokinetic parameters AUC0-12 h, AUC0-∞ and MRT0-12 h of tacrolimus in rats were decreased significantly in group three (P<0.05),while there was no statistical significance in all pharmacokinetic parameters of tacrolimus in group four (P>0.05). Compared with group two, AUC0-12 h of tacrolimus was decreased significantly while CLz was increased significantly in group four (P<0.05); there was no statistical significance in all pharmacokinetic parameters of tacrolimus in group five (P>0.05). CONCLUSIONS: Single and multiple intragastric administration of berberine hydrochloride has a certain effect on the pharmacokinetics of tacrolimus in rats, it shows that there is a downward trend in blood drug concentration and needs to be used with caution.